NASDAQ : GTBP

GT Biopharma, Inc.

$0.3559 USD

-$0.03 (-7.2%)

Volume
496.98K
Average Volume
1.55M
Market Capitalization
$3.78M
P/E Ratio
-0.06
Dividend Yield
0.00%
Price Target
Year High
$2.29
Year Low
$0.26
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.69
Insider Activity Summary (Last 12 Months)
Insiders Buying

12

Insiders Selling

1

Amount of Insider Selling

$100000

GTBP Insider Buying/Selling by Quarter
GTBP Insider Trading History
Insider Name Title Date Transaction Cost Filing Date
Mun-Gavin David C. director 2025-09-04 A-Award 1.33 2025-09-08
Breen Michael Martin director, officer: CEO and Director 2025-09-04 A-Award 1.33 2025-09-08
URBAN ALAN LOUIS officer: Chief Financial Officer 2025-09-04 A-Award 1.33 2025-09-08
CASAMENTO CHARLES J director 2025-09-04 A-Award 1.33 2025-09-08
Kramer Hilary director 2025-09-04 A-Award 1.33 2025-09-08
Mun-Gavin David C. director: 2025-06-10 0 2025-07-30
Kramer Hilary director: 2025-05-07 0 2025-06-03
Ritter Andrew J director: 2025-05-08 0 2025-05-29
URBAN ALAN LOUIS officer: Chief Financial Officer 2024-10-17 A-Award 2.11 2024-10-21
URBAN ALAN LOUIS officer 2024-06-03 0 2024-06-13
Breen Michael Martin director, officer: Executive Chairman/Interim CEO 2023-08-11 A-Award 0.287 2023-08-15
Ohri Manu officer: CFO & Secretary 2023-08-11 J-Other 0.287 2023-08-15
Ohri Manu officer: CFO & Secretary 2023-08-11 A-Award 0.287 2023-08-15
Ohri Manu officer: CFO & Secretary 2023-08-11 J-Other 0.287 2023-08-15
CASAMENTO CHARLES J director 2023-06-16 A-Award 0.35 2023-06-21
CASAMENTO CHARLES J director: 2023-05-01 0 2023-05-04
Breen Michael Martin director, officer: Executive Chairman/Interim CEO 2023-04-11 P-Purchase 0.5 2023-04-11
Ohri Manu officer: CFO & Secretary 2023-04-06 P-Purchase 0.5 2023-04-10
Breen Michael Martin director, officer: Exec Chairman and Interim CEO 2023-01-27 A-Award 0.837 2023-02-01
SHROTRIYA RAJESH C MD director 2023-01-27 A-Award 0.837 2023-02-01
Ohri Manu officer: Chief Financial Officer 2023-01-27 A-Award 0.837 2023-02-01
Wendel Bruce director 2023-01-27 A-Award 0.837 2023-02-01
Breen Michael Martin officer: Exec. Chair. and Interim CEO 2022-07-15 A-Award 0 2022-07-19
SHROTRIYA RAJESH C MD director: 2022-07-15 A-Award 0 2022-07-19
URBAN ALAN LOUIS director 2022-07-15 A-Award 2.48 2022-07-19
URBAN ALAN LOUIS director: 2022-07-15 A-Award 0 2022-07-19
Berk Gregory officer: Pres. of R&D, CMO 2022-07-15 A-Award 2.48 2022-07-19
Berk Gregory officer: Pres. of R&D, CMO 2022-07-15 A-Award 0 2022-07-19
Ohri Manu officer: CFO & Secretary 2022-07-15 A-Award 0 2022-07-19
Ohri Manu officer: CFO & Secretary 2022-07-15 J-Other 0 2022-07-19
Wendel Bruce director: 2022-07-15 A-Award 0 2022-07-19
URBAN ALAN LOUIS director: 2022-06-09 0 2022-06-14
Ohri Manu 2022-02-14 0 2022-02-18
Berk Gregory 2021-02-16 A-Award 0 2022-02-14
Berk Gregory 2021-02-16 A-Award 6.33 2022-02-14
SHROTRIYA RAJESH C MD 2021-02-16 A-Award 6.33 2022-02-14
Choy Gavin 2021-12-31 A-Award 3.05 2022-02-14
Berk Gregory 2020-11-11 0 2022-02-14
Choy Gavin 2021-11-28 0 2022-02-14
SHROTRIYA RAJESH C MD 2021-01-13 0 2022-02-14
Breen Michael Martin 2021-02-25 C-Conversion 3.4 2021-11-12
Breen Michael Martin 2021-02-25 C-Conversion 3.4 2021-11-12
Breen Michael Martin 2021-02-16 A-Award 0 2021-11-12
Breen Michael Martin 2021-02-16 A-Award 6.33 2021-11-12
Breen Michael Martin 2021-02-25 C-Conversion 3.4 2021-11-12
Breen Michael Martin 2020-06-23 3.4 2021-11-12
Wendel Bruce 2021-02-16 A-Award 0 2021-10-07
Wendel Bruce 2021-02-16 A-Award 6.33 2021-10-07
Wendel Bruce 2020-12-22 P-Purchase 8.73 2021-10-07
Wendel Bruce 2020-12-22 P-Purchase 8.87 2021-10-07
Wendel Bruce 2020-11-16 P-Purchase 3.14 2021-10-07
Wendel Bruce 2020-11-11 0 2021-10-07
Weldon Steven W 2020-12-21 S-Sale 0.3 2020-12-23
Weldon Steven W 2020-12-21 S-Sale 0.33 2020-12-23
Weldon Steven W 2020-12-21 S-Sale 0.34 2020-12-23
Weldon Steven W 2020-12-22 S-Sale 0.4 2020-12-23
Weldon Steven W 2020-12-16 S-Sale 0.3 2020-12-18
Weldon Steven W 2020-12-17 S-Sale 0.3 2020-12-18
Weldon Steven W 2020-12-17 S-Sale 0.31 2020-12-18
Weldon Steven W 2020-12-18 S-Sale 0.3 2020-12-18
Weldon Steven W 2020-12-11 S-Sale 0.25 2020-12-15
Weldon Steven W 2020-12-11 S-Sale 0.26 2020-12-15
Weldon Steven W 2020-12-14 S-Sale 0.28 2020-12-15
Weldon Steven W 2020-12-14 S-Sale 0.29 2020-12-15
Weldon Steven W 2020-12-14 S-Sale 0.29 2020-12-15
Weldon Steven W 2020-12-15 S-Sale 0.3 2020-12-15
Weldon Steven W 2020-12-15 S-Sale 0.3 2020-12-15
Weldon Steven W 2020-12-15 S-Sale 0.32 2020-12-15
Cataldo Tony director, 10 percent owner, officer: CEO 2020-06-02 S-Sale 0.001 2020-06-04
Weldon Steven W director, officer: CFO 2020-05-13 S-Sale 0.001 2020-05-14
Cataldo Tony director, 10 percent owner, officer: CEO 2019-08-14 A-Award 0 2019-08-16
Weldon Steven W director, 10 percent owner, officer: CFO 2019-08-14 A-Award 0 2019-08-16
Urbanski Raymond W. director, officer: CEO 2019-02-01 S-Sale 0.001 2019-03-19
Cataldo Tony director 2019-02-06 S-Sale 0.001 2019-02-13
Cross Shawn 2017-11-16 0 2018-03-16
Cataldo Tony director, 10 percent owner, officer: Executive Chairman 2017-09-01 A-Award 0 2017-12-01
Cataldo Tony director, 10 percent owner, officer: Executive Chairman 2017-11-02 G-Gift 0 2017-12-01
Cataldo Tony director, 10 percent owner, officer: Executive Chairman 2017-11-02 G-Gift 0 2017-12-01
Cataldo Tony director, 10 percent owner, officer: Executive Chairman 2017-11-02 G-Gift 0 2017-12-01
Urbanski Raymond W. officer: Chief Medical Officer 2017-09-01 0 2017-12-01
Clarence-Smith Kathleen director, 10 percent owner, officer: CEO 2017-09-01 0 2017-12-01
Weldon Steven W director, officer: CFO 2017-09-01 A-Award 0 2017-12-01
Silverman Mark J 10 percent owner 2017-09-01 0 2017-12-01
BRISTOL INVESTMENT FUND LTD 10 percent owner 2016-04-04 S-Sale 303750 2016-04-05
BRISTOL INVESTMENT FUND LTD 10 percent owner 2016-04-05 J-Other 0 2016-04-05
BRISTOL INVESTMENT FUND LTD 10 percent owner 2016-02-09 0 2016-03-02
Cataldo Tony director, 10 percent owner, officer: CEO 2016-01-25 0 2016-02-23
Weldon Steven W director, officer: CFO 2016-01-25 0 2016-02-12
BRISTOL INVESTMENT FUND LTD 10 percent owner 2016-01-13 0 2016-01-25
BRISTOL INVESTMENT FUND LTD 10 percent owner 2016-01-13 1.25 2016-01-25
Saloff David director, officer: CEO, Chairman of the Board 2012-03-01 A-Award 0.04 2012-05-30
Saloff David director, officer: Chief Executive Officer 2011-08-31 A-Award 0.0535 2011-09-01
Saloff David director 2011-06-30 0.09 2011-07-11
Eaton Kenneth Haynes director 2011-06-27 0.09 2011-07-07
DUBE ANSHUMAN director 2011-05-20 P-Purchase 0.1 2011-05-24
HOOG THOMAS W director 2010-10-01 0.11 2011-02-08
DUBE ANSHUMAN director, 10 percent owner: 2010-12-23 C-Conversion 0.05 2011-01-19
DUBE ANSHUMAN director, 10 percent owner: 2010-12-23 C-Conversion 0.05 2011-01-19
DUBE ANSHUMAN director, 10 percent owner: 2010-12-23 S-Sale 0.13 2011-01-19
DUBE ANSHUMAN director, 10 percent owner: 2010-12-27 S-Sale 0.1311 2011-01-19